Search Term:  BOKEMEYER C.  see all results for bokemeyer Bokemeyer C. Author 10 Jahre Arbeitsgruppe Geriatrische Onkologie der DGHO/DGG/AIO     Onkologie 2009, Band 32, Suppl. 3 Author A 63-Year-Old Patient with Multicentric Castleman's Disease and Severe Polyradiculitis     Onkologie 1997, Vol. 20, No. 6 Author A Pilot Study of Docetaxel and Trofosfamide as Second-Line 'Metronomic' Chemotherapy in the Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC)     Onkologie 2008, Vol. 31, No. 4 Author AIO - Arbeitsgemeinschaft Internistische Onkologie in der Deutschen Krebsgesellschaft e.V.     Onkologie 2004, Vol. 27, No. 4 Author Alteration of thep53Tumor Suppressor Gene in Prostate Cancer: Analytical Approaches and Clinical Implications     Onkologie 1998, Vol. 21, No. 2 Author Anaphylactoid Type Reaction in a Patient Receiving High-Dose Methotrexate Chemotherapy     Onkologie 1992, Vol. 15, No. 4 Author Aprepitant as Salvage Therapy in Patients with Chemotherapy-Induced Nausea and Emesis Refractory to Prophylaxis with 5-HT3 Antagonists and Dexamethasone     Onkologie 2006, Vol. 29, No. 12 Author Behandlung des multiplen Myeloms bei älteren Patienten: Konsensus der Arbeitsgruppe Geriatrische Onkologie der DGHO und DGG     Onkologie 2001, Vol. 24, No. 4 Author Biirstner 0, et al: De novo malignancies following renal transplantation: Experience of a single center. Onkologie 1995;18:32-38.     Onkologie 1995, Vol. 18, No. 3 Author Cancer-Related Anemia: Pathogenesis, Prevalence and Treatment     Oncology 2005, Vol. 68, Suppl. 1 Author Chemotherapie des fortgeschrittenen kolorektalen Karzinoms: Behandlungsoptionen für ältere Patienten     Onkologie 2003, Band 26, Suppl. 7 Author Chemotherapie des kolorektalen Karzinoms - welche Therapie ist bei älteren Patienten gerechtfertigt?     Onkologie 2001, Vol. 24, No. 1 Author Chemotherapy in Elderly Patients with Advanced Lung Cancer Part II: Treatment of Non-Small Cell Lung Cancer (NSCLC)     Onkologie 2004, Vol. 27, No. 6 Author Chemotherapy in Elderly Patients with Advanced Lung Cancer. Part I: General Aspects and Treatment of Small Cell Lung Cancer (SCLC)     Onkologie 2004, Vol. 27, No. 5 Author Current Trends in Chemotherapy for Metastatic Nonseminomatous Testicular Germ Cell Tumors     Oncology 1998, Vol. 55, No. 3 Author Cytomegalovirus, Oxidative Stress and Inflammation as Interdependent Pathomechanisms: Need for Novel Therapeutic Strategies?     CMV-Related Immunopathology Author Diarrhea and Constipation     Supportive Care in Cancer Patients Author Elderly Patients with Acute Myeloid Leukaemia: Characteristics in Biology, Patients and Treatment. Recommendations of the Working Group Geriatric Oncology of the German Society for Haematology and Oncology (DGHO), the Austrian Society for Haematology and Oncology (ÖGHO) and the German Society for Geriatrics (DGG)     Onkologie 2004, Vol. 27, No. 1 Author Empfehlungen des Arbeitskreises «Supportive Maßnahmen in der Onkologie» zur klinischen Anwendung von Zytoprotektiva     Onkologie 2001, Vol. 24, No. 1 Author Evaluation of Late Nephrotoxicity in Long-Term Survivors of Hodgkin's Disease     Oncology 1996, Vol. 53, No. 1 Author First-Line High-Dose Chemotherapy for 'Poor Risk' Metastatic Non-Seminomatous Testicular Germ Cell Tumors     Onkologie 1998, Band 21, Suppl. 2 Author Gefitinib in Combination with Oxaliplatin and 5-Fluorouracil in Irinotecan-Refractory Patients with Colorectal Cancer: A Phase I Study of the Arbeits gemeinschaft Internistische Onkologie (AIO)     Onkologie 2008, Vol. 31, No. 5 Author Independent Risk Factors for Anemia in Cancer Patients Receiving Chemotherapy: Results from the European Cancer Anaemia Survey     Oncology 2006, Vol. 70, No. 1 Author Interaction between Helicobacter pylori and Human Gastric Epithelial Cells in Culture: Effect of Antiulcer Drugs     Pharmacology 1994, Vol. 49, No. 4 Author Irinotecan - klinischer Fortschritt in der Second-line-Therapie des fortgeschrittenen Kolorektalkarzinoms     Onkologie 2000, Band 23, Suppl. 6 Author Is Continuous 24-Hour Infusion of 5-Fluorouracil plus High-Dose Folinic Acid Effective in Patients with Progressive or Recurrent Colorectal Cancer?     Oncology 1998, Vol. 55, No. 4 Author Is There a Need for Pharmacokinetically Guided Carboplatin Dose Schedules?     Onkologie 1997, Vol. 20, No. 4 Author Long-Term Survival after Second-Line Therapy with Docetaxel and Carboplatin and Monthly Pamidronic Acid in a Woman with Metastatic Non-Small Cell Lung Cancer     Onkologie 2006, Vol. 29, No. 5 Author Management of Invasive Fungal Infections in Oncological Patients     Onkologie 1999, Vol. 22, No. 3 Author Metastatic Bone Marrow Involvement in Malignant Germ Cell Tumors     Onkologie 1992, Vol. 15, No. 5 Author Mitomycin C plus Infusional 5-Fluorouracil in Platinum-Refractory Gastric Adenocarcinoma: An Extended Multicenter Phase II Study     Onkologie 2007, Vol. 30, No. 5 Author New Aspects for the Diagnosis of Invasive Fungal Disease in Oncological Patients     Onkologie 1997, Vol. 20, No. 2 Author New Guidelines on Anaemia Management in Patients with Cancer: How Do These Affect Clinical Practice?     Oncology 2005, Vol. 69, Suppl. 2 Author Nonseminomatous Testicular Cancers in Clinical Stage IIA/B: Primary Chemotherapy or Primary Lymphadenectomy?     Onkologie 1998, Vol. 21, No. 6 Author Passive Immuntherapie mit monoklonalen Antikörpern     Onkologie 2005, Band 28, Suppl. 4 Author Phase II Evaluation of 5-Fluorouracil plus Folinic Acid and Alpha 2b-lnterferon in Metastatic Colorectal Cancer     Oncology 1997, Vol. 54, No. 2 Author Primary Osteogenic Sarcoma of the Breast: Report of a Case and a Short Review of the Literature     Onkologie 1995, Vol. 18, No. 4 Author Register und Studienaktivitäten in der Geriatrischen Onkologie     Onkologie 2009, Band 32, Suppl. 3 Author Registerstudie für die Behandlung von Hirnmetastasen maligner Hodentumoren     Onkologie 1998, Vol. 21, No. 3 Author Safe Use of Oxaliplatin in a Patient with Metastatic Breast Cancer and Combined Renal and Hepatic Failure*     Onkologie 2006, Vol. 29, No. 6 Author Single-Center Management of 136 Patients with Cancer of Unknown Primary Site (CUP Syndrome) Over a Period of 10 Years     Onkologie 2009, Vol. 32, No. 12 Author The Local Cytokine and Chemokine Milieu within Malignant Effusions     Tumor Biology 2008, Vol. 29, No. 2 Author The Potential Role of Topotecan in the Treatment of Pediatric and Adult Soft-Tissue Sarcomas     Onkologie 1998, Vol. 21, Suppl. 4 Author The Prognostic Role of Alterations of the p53 Tumor Suppressor Gene in Superficial and Advanced Stage Bladder Cancer     Onkologie 1995, Vol. 18, No. 3 Author The Situation of Elderly Cancer Patients     Onkologie 2001, Vol. 24, No. 4 Author Therapy-Related Leukemia following High-Dose Chemotherapy: Compensating for the Benefit?     Onkologie 2000, Vol. 23, No. 5 Author Topotecan - A Novel Topoisomerase I Inhibitor: Pharmacology and Clinical Experience     Oncology 1999, Vol. 56, No. 1 Author Treatment of Adult Soft-Tissue Sarcomas with Dose-Intensified Chemotherapy and Haematopoietic Growth Factors     Onkologie 1994, Vol. 17, No. 3 Author Treatment of Relapsed Nonseminomatous Germ Cell Tumors with Vinorelbine: A Trial of the Phase 1/11 Study Group of the Association for Medical Oncology of the German Cancer Society     Onkologie 1993, Vol. 16, No. 1 Author Use of Hematopoietic Growth Factors in Elderly Patients Receiving Cytotoxic Chemotherapy     Onkologie 2002, Band 25, No. 1 Author Vorwort: «Targeted therapy in oncology» – von der Forschung zur klinischen Praxis     Onkologie 2005, Band 28, Suppl. 4 Author Wilsede Schule für Onkologie und Hämatologie     Onkologie 1992, Vol. 15, No. 5 Bokemeyer C., Hamburg Editor Geriatrische Onkologie  (2009) Editor Zielgerichtete Tumortherapie  (2005) Bokemeyer C., Tübingen Editor Paraneoplastic Syndromes  (1998)  © 2009 S. Karger AG, Basel